Cutaneous side effects of alpha interferon;Manifestations cutanées au cours des traitements par interféron

Presse Medicale

Volumn 34, Issue 21, 2005, Pages 1668-1672

  Descamps, V ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA1A INTERFERON; CONSENSUS INTERFERON; INTERFERON BETA SERINE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; RECOMBINANT GAMMA INTERFERON;

ALOPECIA; ATOPIC DERMATITIS; CLINICAL FEATURE; DISEASE EXACERBATION; DRUG ERUPTION; DRUG INDICATION; DRY SKIN; ECZEMA; ERYTHEMA; HAIR LOSS; HUMAN; HYPERTRICHOSIS; INJECTION SITE REACTION; MACULOPAPULAR RASH; PAPULOVESICULAR RASH; PHOTOSENSITIVITY; PRURITUS; PSORIASIS; RASH; RAYNAUD PHENOMENON; REVIEW; SARCOIDOSIS; SKIN DISCOLORATION; SKIN DISEASE; SKIN MANIFESTATION; SKIN NECROSIS; URTICARIA;

EID: 30344441533     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(05)84245-9     Document Type: Short Survey

References (44)

1. Charron A, Bessis D, Dereure O, Guilhou JJ, Guillot B. Effets secondaires cutanés locaux des interférons. Presse Med 2001; 30: 1555-60.
2. Manjon-Haces JA, Vazquez-Lopez F, Gomez-Diez S, Hidalgo-Garcia A, Perez-Alvarez R, Soler-Sanchez T et al. Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus. Acta Derm Venereol 2001; 81: 223.
3. Sookoian S, Neglia V, Castano G, Frider B, Kien MC, Choheula E. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol 1999; 135: 1000-1.
4. Guillot B, Blazquez L, Bessis D, Dereure O, Guilhou JJ. A prospective study of cutaneous adverse events induced by low-dose alpha-interferon treatment for malignant melanoma. Dermatology 2004; 208: 49-54.
5. Kurzen H, Petzoldt D, Hartschuh W, Jappe U. Cutaneous necrosis after subcutaneous injection of polyethylene-glycol-modified interferon alpha. Acta Derm Venereol 2002; 82: 310-12.
6. Bessis D, Charron A, Rouzier-Panis R, Blatiere V, Guilhou JJ, Reynes J. Necrotizing cutaneous lesions complicating treatment with pegylated-interferon alfa in an HIV-infected patient. Eur J Dermatol 2002; 12: 99-102.
7. Sparsa A, Loustaud-Ratti V, Liozon E, Denes E, Soria P, Bouyssou-Gauthier ML et al. Réactions cutanées ou nécrose à l'interféron alpha: peut-on reprendre l'interféron? À propos de six cas. Rev Med Interne 2000; 21: 756-63.
8. Gallina K, Brodell RT, Naffah F, Nedorost S. Local blistering reaction complicating subcutaneous injection of pegylated interferon in a patient with hepatitis C. J Drugs Dermatol 2003; 2: 63-7.
9. Bugatti L, Filosa G, Nicolini M, Filosa A, Verdolini R. Atrophie blanche associated with interferon-alfa adjuvant therapy for melanoma: a cutaneous side effect related to the procoagulant activity of interferon? Dermatology 2002; 204: 154.
10. Berger L, Descamps V, Marck Y, Dehen L, Grossin M, Crickx B et al. Eczéma induit par l'interféron chez des malades atopiques infectés par le virus de l'hépatite C : 4 observations. Ann Dermatol Venereol 2000; 127: 51-5.
11. Toyofuku K, Imayama S, Yasumoto S, Kiryu H, Hori Y. Clinical and immunohistochemical studies of skin eruption: relationship to administration of interferon-alpha. J Dermatol 1994; 21: 732-7.
12. Dereure O, Raison-Peyron N, Larrey D, Blanc F, Guilhou JJ. Diffuse inflammatory lesions in patients treated with interferon alfa and ribavirin for hepatitis C: a series of 20 patients. Br J Dermatol 2002; 147: 1142-6.
13. Moore MM, Elpern DJ, Carter DJ. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol 2004; 140: 215-17.
14. Detmar U, Agathos M, Nerl C. Allergy of delayed type to recombinant interferon alpha 2c. Contact Dermatitis 1989; 20: 149-50.
15. Lanigan SW. Straight hair associated with interferon alfa plus ribavirin in hepatitis C infection. Br J Dermatol 2003; 148: 595.
16. Misery L. Diffuse hypertrichosis in the course of hepatitis C treatment by IFN-alpha andribavirin. J Interferon Cytokine Res 2002; 22: 881-2.
17. Lang AM, Norland AM, Schuneman RL, Tope WD. Localized interferon alpha-2b-induced alopecia. Arch Dermatol 1999; 135: 1126-8.
18. Wendling J, Descamps V, Grossin M, Marcellin P, Le Bozec P, Belaich S et al. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepatitis C. Arch Dermatol 2002; 138: 546-7.
19. Leclerc S, Myers RP, Moussalli J, Herson S, Poynard T, Benveniste O. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Intern Med 2003; 14: 237-43.
20. Nawras A, Alsolaiman MM, Mehboob S, Bartholomew C, Maliakkal B. Systemic Sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci 2002; 47: 1627-31.
21. Cogrel O, Doutre MS, Marliere V, Beylot-Barry M, Couzigou P, Beylot C. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases. Br J Dermatol 2002; 146: 320-4.
22. Neglia V, Sookoian S, Herrera M, Abeldano A, Kien MC, Chouela E et al. Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b. J Cutan Med Surg 2001; 5: 406-8.
23. Nawras A, Alsolaiman MM, Mehboob S, Bartholomew C, Maliakkal B. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci 2002; 47: 1627-31.
24. Toulemonde A, Quereux G, Dreno B. Granulome sarcoïdosique sur tatouage induit par l'interféron alpha. Ann Dermatol Venereol 2004; 131: 49-51.
25. Rogers CJ, Romagosa R, Vincek V. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C. J Am Acad Dermatol 2004; 50: 649-50.
26. Taylor C, Burns DA, Wiselka MJ. Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C. Postgrad Med J 2000; 76: 365-7.
27. Seckin D, Durusoy C, Sahin S. Concomitant vitiligo and psoriasis in a patient treated with interferon alfa-2a for chronic hepatitis B infection. Pediatr Dermatol 2004; 21: 577-9.
28. Alric L, Plaisier E, Thebault S, Peron JM, Rostaing L, Pourrat J et al. Influence of antiviral therapy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis 2004; 43: 617-23.
29. Auzerie V, Chiali A, Bussel A, Brouet JC, Fermand JP, Dubertret L et al. Leg ulcers associated with cryoglobulinemia: clinical study of 15 patients and response to treatment. Arch Dermatol 2003; 139: 391-3.
30. Sheikh MY, Wright RA, Burruss JB. Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C. Dig Dis Sci 1998; 43: 529-33.
31. Doutre MS, Couzigou P, Beylot-Barry M, Beylot C, Quinton A. Lichen plan et hépatite C. Hétérogénéité de l'évolution de 6 cas traités par interféron alpha. Gastroenterol Clin Biol 1996; 20: 709-10.
32. Krischer J, Pechère M, Salomon D, Harms M, Chavaz, P, Saurat JH. Interferon alfa-2b-induced Meyerson's nevi in a patient with dysplastic nevus syndrome. J Am Acad Dermatol 1999; 40: 105 6.
33. Girard C, Bessis D, Blatière V, Guilhou J, Guillot B. Meyerson's phenomenon induced by interferon-alfa plus ribavirin in hepatitis C infection. Br J Dermatol 2005; 152: 82.
34. Sidhu-Malik NK, Kaplan AL. Multiple fixed drug eruption with interferon/ribavirin combination therapy for hepatitis C virus infection. J Drugs Dermatol 2003; 2: 570-3.
35. Elgart GW, Sheremala W, Ahn YS. Cutaneous reactions to recombinant human interferon beta-1b: the clinical and histologic spectrum. J Am Acad Dermatol 1997; 37: 553-8.
36. Yang CH, Chen CH, Chan HL. Skin necrosis following a recombinant interferon-beta-1b injection. Chang Gung Med J 2002; 25: 774-7.
37. Casoni F, Merelli E, Bedin R, Martella A, Cesinaro A, Bertolotto A. Necrotizing skin lesions and NABs development in a multiple sclerosis patient treated with IFNbeta 1b. Mult Scler 2003; 9: 420-3.
38. Inafuku H, Kasem Khan MA, Nagala T, Nonaka S. Cutaneous ulcerations following subcutaneous interferon beta injection to a patient with multiple sclerosis. J Dermatol 2004; 31: 671-7.
39. Gallelli L, Guadagnino V, Caroleo B, Marigliano N, De Sarro G. Cutaneous ulceration induced by interferon alfa. Ann Pharmacother 2004; 38: 173-4.
40. Debat Zoguereh D, Boucraut J, Beau-Salinas F, Bodiguel E, Lechapois D, Pomet E. Vascularite cutanée avec atteinte rénale compliquant un traitement par interféron bêta-1a pour une sclérose en plaques. Rev Neurol 2004; 160: 1081-4.
41. Frohman EM, Brannon K, Alexander S, Sims D, Phillips JT, O'Leary S et al. Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment and management. Mult Scler 2004; 10: 302-7.
42. Kumar N, Rodriguez M. Scleromyxedema in a patient with multiple sclerosis and monoclonal gammopathy on interferon bela-1a. Mult Scler 2004; 10: 85-6.
43. Leon J, Borbujo J, Cortes L. Cutaneous mucinoses complicating interferon beta-1b therapy. Eur Neurol 2002; 47: 123-4.
44. Grassegger A, Hopfl R. Significance of the cytokine interferon gamma in clinical dermatology. Clin Exp Dermatol 2004; 29: 584-8.